Showing results (1941-1950 of 2,030) with videos related to
Sort By:
Pageof 203
Annals of Surgical Oncology|October 8, 2022
Prognosis of Patients with Cutaneous Angiosarcoma After Surgical Resection with Curative Intent: Is There a Difference Between the Subtypes?Sophie J M Reijers, Eva A Huis In 't Veld, Dirk J Grünhagen, et al.Eclinicalmedicine|October 4, 2021
Does tuberculosis screening improve individual outcomes? A systematic reviewL Telisinghe, M Ruperez, M Amofa-Sekyi, et al.Open Forum Infectious Diseases|September 24, 2021
Association of Female Genital Schistosomiasis With the Cervicovaginal Microbiota and Sexually Transmitted Infections in Zambian WomenAmy S Sturt, Emily L Webb, Lisa Himschoot, et al.Nature Plants|June 19, 2019
Breeding improves wheat productivity under contrasting agrochemical input levelsKai P Voss-Fels, Andreas Stahl, Benjamin Wittkop, et al.The Lancet. Global Health|September 16, 2022
Immunogenicity and safety of one-dose human papillomavirus vaccine compared with two or three doses in Tanzanian girls (DoRIS): an open-label, randomised, non-inferiority trialDeborah Watson-Jones, John Changalucha, Hilary Whitworth, et al.Annals of Surgical Oncology|March 29, 2023
Oncological Outcome After Lymph Node Dissection for Cutaneous Squamous Cell CarcinomaEva A Huis In 't Veld, Thomas Boere, Charlotte L Zuur, et al.Cancer|January 3, 2019
Radiotherapy for retroperitoneal liposarcoma: A report from the Transatlantic Retroperitoneal Sarcoma Working GroupRick L M Haas, Sylvie Bonvalot, Rosalba Miceli, et al.Nature Communications|November 5, 2016
Selenium single-wavelength anomalous diffraction de novo phasing using an X-ray-free electron laserMark S Hunter, Chun Hong Yoon, Hasan DeMirci, et al.Cancer|February 3, 2017
Post-relapse outcomes after primary extended resection of retroperitoneal sarcoma: A report from the Trans-Atlantic RPS Working GroupAndrea J MacNeill, Rosalba Miceli, Dirk C Strauss, et al.Journal of Medicinal Chemistry|September 5, 2003
Design, parallel synthesis, and crystal structures of pyrazinone antithrombotics as selective inhibitors of the tissue factor VIIa complexJohn J Parlow, Brenda L Case, Thomas A Dice, et al.Pageof 203